uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
Show others and affiliations
2008 (English)In: Current Medical Research and Opinion, ISSN 0300-7995, Vol. 24, no 2, 377-384 p.Article in journal (Refereed) Published
Abstract [en]

Objective: The European Forsteo* Observational Study (EFOS) study was primarily designed to assess fracture incidence, degree of pain, health-related quality of life (HRQoL) and compliance in women prescribed teriparatide in a community setting. This report describes the design of the study and characteristics of the patients at entry.

Methods: At entry, 1645 postmenopausal women with a diagnosis of osteoporosis and about to initiate teriparatide treatment were enrolled in eight European countries. Baseline data were collected on demographic characteristics, medical and osteoporosis history, disease status, prior use of medications and HRQoL.

Results: The mean (standard deviation [SD]) age of patients was 71.5 (8.4) years, lumbar spine bone mineral density (BMD) Tscore was –3.3 (1.2), the mean number of previous fractures reported after 40 years of age was 2.9 (2.0), 70% had two or more vertebral deformities and 91.7% were pre-treated with bisphosphonates. HRQoL, evaluated by the health state value (HSV) (median: 0.59, Q1; Q3: 0.08; 0.71) and visual analogue scale (VAS) (median 50.0, Q1; Q3: 35.0; 69.0) status of the European quality of life questionnaire (EQ5D) was poor. Extreme problems were reported by 31% of patients for the pain/discomfort dimension, mobility was limited in 69% and anxiety/depression was reported by 57% of patients. Chronic or intermittent back pain was reported by 91% of patients, which occurred every day or almost every day within the last month in 66% of patients.

Conclusions: The post-menopausal women prescribed teriparatide were severely osteoporotic, with a high fracture risk and poor HRQoL, despite previous therapy for osteoporosis. Moderate to severe back pain was very common.

Place, publisher, year, edition, pages
2008. Vol. 24, no 2, 377-384 p.
Keyword [en]
Back pain, EQ-5D, Fracture, Menopause, Osteoporosis, Quality of life, Teriparatide
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-14749DOI: 10.1185/030079908X261087ISI: 000253902900009PubMedID: 18154690OAI: oai:DiVA.org:uu-14749DiVA: diva2:42520
Available from: 2008-01-31 Created: 2008-01-31 Last updated: 2010-04-29Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=18154690&dopt=Citation

Search in DiVA

By author/editor
Ljunggren, Östen
By organisation
Department of Medical Sciences
In the same journal
Current Medical Research and Opinion
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 166 hits
ReferencesLink to record
Permanent link

Direct link